A research study within the US Military Health System deploys Clinical ink’s platform among those with and without COVID-19 to understand long COVID Horsham, PA; …
Oxford NeuroMetrology Group Successfully Deploys Clinical ink Mobile Platform to Monitor Parkinson’s Patients at Home Horsham, Pa.; August 11, 2022 — Clinical ink, a global …
85% accuracy in early Parkinson’s classification establishes Clinical ink as the industry leader in patient science and digital biomarkers.
JAMA publication demonstrates assessment validity, points to future research and real-world applications Horsham, Pa.; February 16, 2022 — Clinical ink, a global clinical technology company, …
Clinical ink’s technology deployed for groundbreaking cannabis research Read More…
HORSHAM, Pa.; April 6, 2021 – Clinical ink, a global clinical trial technology company, today announced it has added its 16th concurrent Phase II/III Alzheimer’s …
Horsham, Pa.; June 2, 2020 – Clinical Ink, a global clinical trial technology company, has helped expedite the study of a treatment for cytokine storm, …
Sales and Solutions
Direct 1.336.714.7402
Support
Toll-Free 1.800.301.5033
Direct 1.336.714.7402
Insert HTML text here.
